Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) are unsatisfied to treat, pressing more effective and innovative treatment regimens. New efficient regimens for MDR-TB have obtained high treatment success rates. However, those regimens without drug susceptibility testing (DST) are also likely t...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Taoping, Sun, Feng, Li, Yang, Chen, Jiazhen, Chen, Xinchang, Li, Rong, Ge, Shijia, Zhao, Yanlin, Zhang, Wenhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888137/
https://www.ncbi.nlm.nih.gov/pubmed/33596848
http://dx.doi.org/10.1186/s12879-021-05870-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888137/
https://www.ncbi.nlm.nih.gov/pubmed/33596848
http://dx.doi.org/10.1186/s12879-021-05870-w

Ejemplares similares